ARTA
PPBT

A.R.T. Advisors’s Purple Biotech PPBT Stock Holding History

A.R.T. Advisors’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19
Closed -$81K – 1602
2017
Q3 		$81K Buy
+19
New +$70.8K ﹤0.01% 1224
2017
Q2 		– Sell
-5
Closed -$21K – 1657
2017
Q1 		$21K Buy
+5
New +$23.9K ﹤0.01% 1371

Other funds holding PPBT

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

A.R.T. Advisors's PPBT Position: Q4 2017 in Review

A.R.T. Advisors sold out of Purple Biotech (PPBT) in Q4 2017, closing a stake of 19 shares — an estimated $81K sold.

A.R.T. Advisors first reported a position in PPBT in Q1 2017 and held it in 2 quarters. The position peaked at $81K in Q3 2017. 6 funds tracked by Wall St. Rank hold PPBT as of Q4 2017.

  • A.R.T. Advisors reported no remaining Purple Biotech position as of Q4 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 19 Purple Biotech shares in Q4 2017, an estimated $81K.
  • A.R.T. Advisors first reported a position in Purple Biotech in Q1 2017 and held it in 2 quarters.
  • A.R.T. Advisors's Purple Biotech position peaked at $81K in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Purple Biotech as of Q4 2017.

Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.